Hide

FocusBar

Subscribe to Premium Member
Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash to Debt 0.041
CYH's Cash to Debt is ranked lower than
55% of the 220 Companies
in the Global Medical Care industry.

( Industry Median: 0.19 vs. CYH: 0.041 )
CYH' s 10-Year Cash to Debt Range
Min: 0   Max: 0.11
Current: 0.04

0
0.11
Equity to Asset 0.164
CYH's Equity to Asset is ranked lower than
55% of the 220 Companies
in the Global Medical Care industry.

( Industry Median: 0.42 vs. CYH: 0.164 )
CYH' s 10-Year Equity to Asset Range
Min: 0.12   Max: 0.45
Current: 0.16

0.12
0.45
Interest Coverage 1.9
CYH's Interest Coverage is ranked higher than
57% of the 220 Companies
in the Global Medical Care industry.

( Industry Median: 3.50 vs. CYH: 1.9 )
CYH' s 10-Year Interest Coverage Range
Min: 1   Max: 4
Current: 1.9

1
4
F-Score: 6
Z-Score: 1.17
M-Score: -2.28
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 9.30
CYH's Operating margin (%) is ranked higher than
72% of the 220 Companies
in the Global Medical Care industry.

( Industry Median: 8.00 vs. CYH: 9.30 )
CYH' s 10-Year Operating margin (%) Range
Min: 6.8   Max: 11.6
Current: 9.3

6.8
11.6
Net-margin (%) 2
CYH's Net-margin (%) is ranked higher than
60% of the 220 Companies
in the Global Medical Care industry.

( Industry Median: 3.40 vs. CYH: 2 )
CYH' s 10-Year Net-margin (%) Range
Min: -1.6   Max: 4.6
Current: 2

-1.6
4.6
ROE (%) 9.7
CYH's ROE (%) is ranked higher than
73% of the 220 Companies
in the Global Medical Care industry.

( Industry Median: 7.60 vs. CYH: 9.7 )
CYH' s 10-Year ROE (%) Range
Min: -7.3   Max: 13
Current: 9.7

-7.3
13
ROA (%) 1.6
CYH's ROA (%) is ranked higher than
58% of the 220 Companies
in the Global Medical Care industry.

( Industry Median: 3.00 vs. CYH: 1.6 )
CYH' s 10-Year ROA (%) Range
Min: -0.9   Max: 4.3
Current: 1.6

-0.9
4.3
ROC (Joel Greenblatt) (%) 14.90
CYH's ROC (Joel Greenblatt) (%) is ranked higher than
64% of the 220 Companies
in the Global Medical Care industry.

( Industry Median: 15.60 vs. CYH: 14.90 )
CYH' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 7.5   Max: 20.2
Current: 14.9

7.5
20.2
Revenue Growth (%) 2.3
CYH's Revenue Growth (%) is ranked higher than
74% of the 220 Companies
in the Global Medical Care industry.

( Industry Median: 0.00 vs. CYH: 2.3 )
CYH' s 10-Year Revenue Growth (%) Range
Min: 0.6   Max: 32
Current: 2.3

0.6
32
EBITDA Growth (%) 4.8
CYH's EBITDA Growth (%) is ranked higher than
84% of the 220 Companies
in the Global Medical Care industry.

( Industry Median: 0.00 vs. CYH: 4.8 )
CYH' s 10-Year EBITDA Growth (%) Range
Min: -0.8   Max: 31.8
Current: 4.8

-0.8
31.8
EPS Growth (%) 2.7
CYH's EPS Growth (%) is ranked higher than
80% of the 220 Companies
in the Global Medical Care industry.

( Industry Median: 0.00 vs. CYH: 2.7 )
CYH' s 10-Year EPS Growth (%) Range
Min: -32.2   Max: 75.1
Current: 2.7

-32.2
75.1
» CYH's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2012

CYH Guru Trades in Q2 2012

Louis Moore Bacon 50,000 sh (New)
Ray Dalio Sold Out
Joel Greenblatt Sold Out
Jim Simons Sold Out
Ron Baron 5,458,069 sh (-0.58%)
Richard Snow 2,972,538 sh (-7.58%)
Steven Cohen 596,484 sh (-45.91%)
» More
Q3 2012

CYH Guru Trades in Q3 2012

Jeremy Grantham 10,108 sh (New)
Larry Robbins 1,633,151 sh (New)
Ron Baron 5,483,627 sh (+0.47%)
Louis Moore Bacon Sold Out
Steven Cohen 547,038 sh (-8.29%)
Richard Snow 2,574,234 sh (-13.4%)
» More
Q4 2012

CYH Guru Trades in Q4 2012

Larry Robbins 8,551,195 sh (+423.6%)
Jeremy Grantham 31,119 sh (unchged)
Ron Baron 5,071,088 sh (-7.52%)
Richard Snow 2,081,225 sh (-19.15%)
Steven Cohen 401,772 sh (-26.56%)
» More
Q1 2013

CYH Guru Trades in Q1 2013

Andreas Halvorsen 1,676,009 sh (New)
John Hussman 350,000 sh (New)
Bruce Kovner 130,000 sh (New)
Lee Ainslie 2,457,028 sh (New)
Ray Dalio 42,107 sh (New)
Jeremy Grantham 55,313 sh (+77.75%)
Larry Robbins 9,015,163 sh (+5.43%)
Ron Baron 5,071,088 sh (unchged)
Richard Snow 1,905,747 sh (-8.43%)
Steven Cohen 1,052 sh (-99.74%)
» More
» Details

Insider Trades

Latest Guru Trades with CYH

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Lee Ainslie 2013-03-31 New Buy1.5%$30.74 - $47.39 $ 48.5822%2457028
John Hussman 2013-03-31 New Buy0.61%$30.74 - $47.39 $ 48.5822%350000
Ray Dalio 2013-03-31 New Buy0.02%$30.74 - $47.39 $ 48.5822%42107
Joel Greenblatt 2012-06-30 Sold Out 0.07%$20.94 - $27.95 $ 48.58110%0
Ray Dalio 2012-06-30 Sold Out 0.05%$20.94 - $27.95 $ 48.58110%0
Ray Dalio 2012-03-31 Add 445.1%0.04%$16.69 - $25.5 $ 48.58151%137163
Joel Greenblatt 2012-03-31 Add 38.77%0.02%$16.69 - $25.5 $ 48.58151%38486
Ray Dalio 2011-12-31 Reduce -98.33%0.36%$15.29 - $21.39 $ 48.58166%25163
Ray Dalio 2011-09-30 Add 56.88%0.14%$16.26 - $27 $ 48.58128%1503661
Joel Greenblatt 2011-09-30 Add 67.43%0.03%$16.26 - $27 $ 48.58127%23506
Joel Greenblatt 2011-06-30 Add 29.63%0.01%$24.27 - $40.81 $ 48.5866%14039
George Soros 2011-06-30 Sold Out $24.27 - $40.81 $ 48.5866%0
Joel Greenblatt 2011-03-31 New Buy0.13%$34.82 - $42.1 $ 48.5827%10830
George Soros 2011-03-31 Add 173.53%0.01%$34.82 - $42.1 $ 48.5827%18600
Mario Gabelli 2011-03-31 Sold Out $34.82 - $42.1 $ 48.5827%0
George Soros 2010-12-31 New Buy$29.29 - $37.94 $ 48.5848%6800
Mario Gabelli 2010-12-31 New Buy$29.29 - $37.94 $ 48.5848%11998
George Soros 2010-09-30 Sold Out 0.01%$26.07 - $33.75 $ 48.5859%0
George Soros 2010-03-31 New Buy0.01%$31.68 - $40.51 $ 48.5836%9500
Premium More recent guru trades are included for Premium Members only!!
» Financial Charts

Peter Lynch Chart

Guru Investment Theses on Community Health Systems Inc

Baron Funds Comments on Community Health Systems Inc. - May 01, 2013

Rural hospital provider Community Health Systems, Inc. (CYH)'s shares rose 54.2% in the first quarter and increased over 114.9% in the last twelve months. The primary driver of performance has been the anticipation of health care reform. Improving admission trends are also contributing to Community Health's multiple expansion from historically depressed levels. (Susan Robbins)

From Baron Funds’ first quarter 2013 letter.


Check out Ron Baron latest stock trades

Top Ranked Articles about Community Health Systems Inc

Baron Funds Comments on Community Health Systems Inc.
Rural hospital provider Community Health Systems, Inc. (CYH)'s shares rose 54.2% in the first quarter and increased over 114.9% in the last twelve months. The primary driver of performance has been the anticipation of health care reform. Improving admission trends are also contributing to Community Health's multiple expansion from historically depressed levels. (Susan Robbins) Read more...
Glenview’s Larry Robbins Declares 8.39% Ownership of Community Health Systems Larry Robbins - Glenview’s Larry Robbins Declares 8.39% Ownership Of Community Health Systems
Larry Robbins, of New York-based Glenview Capital Management, has purchased more than 6 million shares of Community Health Systems Inc. (CYH) as of Nov. 13, according to GuruFocus Real Time Picks. The purchase makes him 8.39 percent owner of the company, and represents an increase of 368.41 percent. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 16.40
CYH's P/E(ttm) is ranked higher than
70% of the 155 Companies
in the Global Medical Care industry.

( Industry Median: 19.60 vs. CYH: 16.40 )
CYH' s 10-Year P/E(ttm) Range
Min: 5.85   Max: 350
Current: 16.4

5.85
350
P/B 1.70
CYH's P/B is ranked higher than
68% of the 179 Companies
in the Global Medical Care industry.

( Industry Median: 2.05 vs. CYH: 1.70 )
CYH' s 10-Year P/B Range
Min: 0.58   Max: 3.9
Current: 1.7

0.58
3.9
P/S 0.34
CYH's P/S is ranked higher than
84% of the 198 Companies
in the Global Medical Care industry.

( Industry Median: 1.06 vs. CYH: 0.34 )
CYH' s 10-Year P/S Range
Min: 0.1   Max: 1.87
Current: 0.34

0.1
1.87
PFCF 6.40
CYH's PFCF is ranked higher than
88% of the 151 Companies
in the Global Medical Care industry.

( Industry Median: 14.50 vs. CYH: 6.40 )
CYH' s 10-Year PFCF Range
Min: 0.15   Max: 1955
Current: 6.4

0.15
1955
EV-to-EBIT 11.8
CYH's EV-to-EBIT is ranked higher than
71% of the 153 Companies
in the Global Medical Care industry.

( Industry Median: 13.85 vs. CYH: 11.8 )
CYH' s 10-Year EV-to-EBIT Range
Min: 8.8   Max: 35.3
Current: 11.8

8.8
35.3
PEG 2.3
CYH's PEG is ranked higher than
72% of the 82 Companies
in the Global Medical Care industry.

( Industry Median: 2.45 vs. CYH: 2.3 )
CYH' s 10-Year PEG Range
Min: 0.19   Max: 6.56
Current: 2.3

0.19
6.56
Shiller P/E 20.3
CYH's Shiller P/E is ranked lower than
100% of the Companies
in the Global Medical Care industry.

( Industry Median: vs. CYH: 20.3 )
CYH' s 10-Year Shiller P/E Range
Min: 7.14   Max: 30.8
Current: 20.3

7.14
30.8

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 2.8
CYH's Price/Net Current Asset Value is ranked higher than
89% of the 148 Companies
in the Global Medical Care industry.

( Industry Median: 9.80 vs. CYH: 2.8 )
CYH' s 10-Year Price/Net Current Asset Value Range
Min: 1.1   Max: 10.5
Current: 2.8

1.1
10.5
Price/DCF (Projected) 0.8
CYH's Price/DCF (Projected) is ranked higher than
63% of the 86 Companies
in the Global Medical Care industry.

( Industry Median: 0.90 vs. CYH: 0.8 )
CYH' s 10-Year Price/DCF (Projected) Range
Min: 0.4   Max: 3.1
Current: 0.8

0.4
3.1
Price/Median PS Value 0.5
CYH's Price/Median PS Value is ranked higher than
88% of the 176 Companies
in the Global Medical Care industry.

( Industry Median: 1.10 vs. CYH: 0.5 )
CYH' s 10-Year Price/Median PS Value Range
Min: 0.1   Max: 2.1
Current: 0.5

0.1
2.1
Price/Peter Lynch Fair Value 1.7
CYH's Price/Peter Lynch Fair Value is ranked higher than
65% of the 34 Companies
in the Global Medical Care industry.

( Industry Median: 2.00 vs. CYH: 1.7 )
CYH' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.3   Max: 6.6
Current: 1.7

0.3
6.6
Earnings Yield (Greenblatt) 8.50
CYH's Earnings Yield (Greenblatt) is ranked higher than
80% of the 220 Companies
in the Global Medical Care industry.

( Industry Median: 5.20 vs. CYH: 8.50 )
CYH' s 10-Year Earnings Yield (Greenblatt) Range
Min: 2.8   Max: 11.3
Current: 8.5

2.8
11.3
Forward Rate of Return (Yacktman) 12.55
CYH's Forward Rate of Return (Yacktman) is ranked higher than
89% of the 220 Companies
in the Global Medical Care industry.

( Industry Median: 0.00 vs. CYH: 12.55 )
CYH' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -23.6   Max: 41.7
Current: 12.55

-23.6
41.7

Business Description

Community Health Systems Inc. was incorporated in 1996 as a Delaware corporation. The Company provides healthcare services through the hospitals that it owns and operates in non-urban and selected urban markets. The Company generates revenue primarily by providing a broad range of general hospital healthcare services to patients in the communities in which it is located. The Company currently owns and operates 133 hospitals comprised of 129 general acute care hospitals and four stand-alone rehabilitation or psychiatric hospitals. In addition, it owns and operates home care agencies, located primarily in markets where it also operates a hospital, and through its wholly-owned subsidiary, Quorum Health Resources, LLC, or QHR, it provides management and consulting services to non-affiliated general acute care hospitals located throughout the United States. The Company generally targets hospitals in growing, non-urban and selected urban healthcare markets for acquisition because of their favorable demographic and economic trends and competitive conditions. Because non-urban service areas have smaller populations, there are generally fewer hospitals and other healthcare service providers in these communities and generally a lower level of managed care presence in these markets. The Company's Medicare is a federal program that provides medical insurance benefits to persons age 65 and over, some disabled persons, and persons with end-stage renal disease. The hospital industry is highly competitive. In addition to the competition it faces for acquisitions, it must also compete with other hospitals and healthcare providers for patients. The Company is subject to various federal, state and local laws and regulations governing the use, discharge and disposal of hazardous materials, including medical waste products.
Company Website
SEC Reports
Industry: Medical Care
Compare:CHE, FMS, DVA, FSNUY, BDUUF
Traded in other countries:CG5.Germany

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK